{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:18:11Z","timestamp":1787689091094,"version":"build-2784847793"},"reference-count":146,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biosafety and Health"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bsheal.2026.06.006","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:44:46Z","timestamp":1782517486000},"page":"239-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The first key for the Priority Pathogens: Protective immunogens in development of vaccines and medications"],"prefix":"10.1016","volume":"8","author":[{"given":"Qian","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Fu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3605-4070","authenticated-orcid":false,"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bsheal.2026.06.006_b0005","unstructured":"World Health Organization, Pathogens prioritization: A scientific framework for epidemic and pandemic research preparedness. https:\/\/www.who.int\/publications\/m\/item\/pathogens-prioritization-a-scientific-framework-for-epidemic-and-pandemic-research-preparedness, 2024 (accessed 19 September 2025)."},{"issue":"12","key":"10.1016\/j.bsheal.2026.06.006_b0010","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.chom.2022.10.018","article-title":"Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection","volume":"30","author":"Brouwer","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"512","key":"10.1016\/j.bsheal.2026.06.006_b0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw3163","article-title":"Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot","volume":"11","author":"Mateo","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0020","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1038\/s41467-023-41376-6","article-title":"A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection","volume":"14","author":"Ronk","year":"2023","journal-title":"Nat. Commun."},{"issue":"8552","key":"10.1016\/j.bsheal.2026.06.006_b0025","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(87)90767-7","article-title":"Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever","volume":"2","author":"Clegg","year":"1987","journal-title":"Lancet"},{"issue":"597","key":"10.1016\/j.bsheal.2026.06.006_b0030","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf6348","article-title":"A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains","volume":"13","author":"Mateo","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0035","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s41467-023-37050-6","article-title":"Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys","volume":"14","author":"Mateo","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bsheal.2026.06.006_b0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/iai.13.3.735-740.1976","article-title":"Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin\/toxoid","volume":"13","author":"Svennerholm","year":"1976","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bsheal.2026.06.006_b0045","first-page":"813","article-title":"Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague","volume":"9","author":"Huang","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.bsheal.2026.06.006_b0050","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/vaccines11030581","article-title":"Rapid induction of protective immunity against pneumonic plague by Yersinia pestis polymeric F1 and LcrV antigens","volume":"11","author":"Aftalion","year":"2023","journal-title":"Vaccines (basel)"},{"issue":"10","key":"10.1016\/j.bsheal.2026.06.006_b0055","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg1036","article-title":"A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium","volume":"9","author":"Kon","year":"2023","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.bsheal.2026.06.006_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31446","article-title":"Recombinant YopE and LcrV vaccine candidates protect mice against plague and yersiniosis","volume":"10","author":"Gupta","year":"2024","journal-title":"Heliyon"},{"issue":"25\u201326","key":"10.1016\/j.bsheal.2026.06.006_b0065","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.bsheal.2026.06.006_b0070","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1128\/IAI.00105-08","article-title":"Yersinia pestis caf1 variants and the limits of plague vaccine protection","volume":"76","author":"Quenee","year":"2008","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.bsheal.2026.06.006_b0075","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4049\/jimmunol.1100174","article-title":"Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague","volume":"187","author":"Lin","year":"2011","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bsheal.2026.06.006_b0080","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftw098","article-title":"Stable expression of Shigella dysenteriae serotype 1 O-antigen genes integrated into the chromosome of live Salmonella oral vaccine vector Ty21a","volume":"74","author":"Dharmasena","year":"2016","journal-title":"Pathog. Dis."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0085","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00346-24","article-title":"A newly developed oral infection mouse model of shigellosis for immunogenicity and protective efficacy studies of a candidate vaccine","volume":"93","author":"Haldar","year":"2025","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bsheal.2026.06.006_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106344","article-title":"Protective immunization against Enterohemorrhagic Escherichia coli and Shigella dysenteriae Type 1 by chitosan nanoparticle loaded with recombinant chimeric antigens comprising EIT and STX1B-IpaD","volume":"184","author":"Mosadegh","year":"2023","journal-title":"Microb. Pathog."},{"issue":"12","key":"10.1016\/j.bsheal.2026.06.006_b0095","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1021\/acsinfecdis.1c00345","article-title":"Development of a self-adjuvanting, cross-protective, stable intranasal recombinant vaccine for shigellosis","volume":"7","author":"Baruah","year":"2021","journal-title":"ACS Infect. Dis."},{"issue":"5","key":"10.1016\/j.bsheal.2026.06.006_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064680","article-title":"Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates","volume":"8","author":"Simon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bsheal.2026.06.006_b0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fcimb.2017.00391","article-title":"Two novel Salmonella bivalent vaccines confer dual protection against two Salmonella serovars in mice","volume":"7","author":"Zhao","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bsheal.2026.06.006_b0110","doi-asserted-by":"crossref","unstructured":"R. Simon, S.M. Tennant, J.Y. Wang, P.J. Schmidlein, A. Lees, R.K. Ernst, M.F. Pasetti, J.E. Galen, M.M. Levine, Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis, Infect. Immun. 79 (10) (2011) 4240\u20134249, https:\/\/doi.org\/10.1128\/IAI.05484-11.","DOI":"10.1128\/IAI.05484-11"},{"issue":"12","key":"10.1016\/j.bsheal.2026.06.006_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005207","article-title":"Role of T3SS-1 SipD protein in protecting mice against non-typhoidal Salmonella Typhimurium","volume":"10","author":"Jneid","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bsheal.2026.06.006_b0120","article-title":"Development of Klebsiella pneumoniae capsule polysaccharide-conjugated vaccine candidates using phage depolymerases","volume":"13","author":"Lin","year":"2022","journal-title":"Front. Immunol."},{"issue":"17\u201318","key":"10.1016\/j.bsheal.2026.06.006_b0125","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/S0264-410X(02)00149-4","article-title":"Streptococcus pneumoniae polysaccharides conjugated to the outer membrane protein a from Klebsiella pneumoniae elicit protective antibodies","volume":"20","author":"Libon","year":"2002","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.bsheal.2026.06.006_b0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1128\/iai.54.2.403-407.1986","article-title":"Immunization against fatal experimental Klebsiella pneumoniae pneumonia","volume":"54","author":"Cryz","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bsheal.2026.06.006_b0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.micpath.2018.04.004","article-title":"Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model","volume":"119","author":"Hussein","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bsheal.2026.06.006_b0140","doi-asserted-by":"crossref","unstructured":"M.X. Rodrigues, Y. Yang, E.B. de Souza Meira, Jr., J. do Carmo Silva, R.C. Bicalho, Development and evaluation of a new recombinant protein vaccine (YidR) against Klebsiella pneumoniae infection, Vaccine 38 (29) (2020) 4640\u20134648, https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.057.","DOI":"10.1016\/j.vaccine.2020.03.057"},{"issue":"3","key":"10.1016\/j.bsheal.2026.06.006_b0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/vaccines13030303","article-title":"Protection against pneumonia induced by vaccination with fimbriae subunits from Klebsiella pneumoniae","volume":"13","author":"Assoni","year":"2025","journal-title":"Vaccines (basel)"},{"key":"10.1016\/j.bsheal.2026.06.006_b0150","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3389\/fmicb.2017.01805","article-title":"Evaluation of recombinant multi-epitope outer membrane protein-based Klebsiella pneumoniae subunit vaccine in mouse model","volume":"8","author":"Babu","year":"2017","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.bsheal.2026.06.006_b0155","article-title":"Mosaic RBD nanoparticles elicit protective immunity against multiple human coronaviruses in animal models","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Sci. (weinh)"},{"issue":"13","key":"10.1016\/j.bsheal.2026.06.006_b0160","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.cell.2022.04.029","article-title":"Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2","volume":"185","author":"Xu","year":"2022","journal-title":"Cell"},{"issue":"28","key":"10.1016\/j.bsheal.2026.06.006_b0165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026207118","article-title":"Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination","volume":"118","author":"Tscherne","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0170","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1080\/22221751.2022.2056524","article-title":"A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates","volume":"11","author":"An","year":"2022","journal-title":"Emerg. Microbes Infect."},{"issue":"12","key":"10.1016\/j.bsheal.2026.06.006_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030525","article-title":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants","volume":"3","author":"Deming","year":"2006","journal-title":"PLoS Med."},{"issue":"6982","key":"10.1016\/j.bsheal.2026.06.006_b0180","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"issue":"38","key":"10.1016\/j.bsheal.2026.06.006_b0185","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2011.06.111","article-title":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.bsheal.2026.06.006_b0190","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway memory CD4+ T cells mediate protective immunity against emerging respiratory coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bsheal.2026.06.006_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823949","article-title":"Inactivated rabies virus vectored MERS-coronavirus vaccine induces protective immunity in mice, camels, and alpacas","volume":"13","author":"Chi","year":"2022","journal-title":"Front. Immunol."},{"issue":"6268","key":"10.1016\/j.bsheal.2026.06.006_b0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels","volume":"351","author":"Haagmans","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bsheal.2026.06.006_b0205","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","article-title":"A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS","volume":"182","author":"Dai","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bsheal.2026.06.006_b0210","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/j.ymthe.2024.08.026","article-title":"Rational design of self-amplifying virus-like vesicles with Ebola virus glycoprotein as vaccines","volume":"32","author":"Zhang","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bsheal.2026.06.006_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.703986","article-title":"Recombinant protein filovirus vaccines protect cynomolgus macaques from Ebola, Sudan, and Marburg viruses","volume":"12","author":"Lehrer","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bsheal.2026.06.006_b0220","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/mt.2013.61","article-title":"Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola","volume":"21","author":"Shedlock","year":"2013","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.bsheal.2026.06.006_b0225","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ymthe.2022.10.011","article-title":"Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection","volume":"31","author":"Krahling","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bsheal.2026.06.006_b0230","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ebiom.2019.09.055","article-title":"Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge","volume":"49","author":"Marzi","year":"2019","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.bsheal.2026.06.006_b0235","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","article-title":"Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein","volume":"75","author":"Wilson","year":"2001","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.bsheal.2026.06.006_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118881","article-title":"Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles","volume":"10","author":"Warfield","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bsheal.2026.06.006_b0245","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/S2666-5247(23)00001-0","article-title":"Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques","volume":"4","author":"Marzi","year":"2023","journal-title":"Lancet Microbe"},{"issue":"675","key":"10.1016\/j.bsheal.2026.06.006_b0250","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq6364","article-title":"A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates","volume":"14","author":"Hunegnaw","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.bsheal.2026.06.006_b0255","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3390\/vaccines10111935","article-title":"3rd, et al., Single-shot ChAd3-MARV vaccine in modified formulation buffer shows 100% protection of NHPs","volume":"10","author":"Finch","year":"2022","journal-title":"Vaccines (basel)"},{"issue":"4","key":"10.1016\/j.bsheal.2026.06.006_b0260","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa1410345","article-title":"AVI-7288 for Marburg virus in nonhuman primates and humans","volume":"373","author":"Heald","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41541-023-00629-7","article-title":"Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models","volume":"8","author":"Medina-Magues","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.bsheal.2026.06.006_b0270","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3389\/fimmu.2018.01756","article-title":"Immunogenicity and protection after vaccination with a modified vaccinia virus Ankara-vectored yellow fever vaccine in the hamster model","volume":"9","author":"Julander","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bsheal.2026.06.006_b0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003693","article-title":"A DNA vaccine against yellow fever virus: development and evaluation","volume":"9","author":"Maciel","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.bsheal.2026.06.006_b0280","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/jvi.60.3.1153-1155.1986","article-title":"Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1","volume":"60","author":"Schlesinger","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.bsheal.2026.06.006_b0285","article-title":"A tetravalent nanoparticle vaccine elicits a balanced and potent immune response against dengue viruses without inducing antibody-dependent enhancement","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bsheal.2026.06.006_b0290","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00239-24","article-title":"A tetravalent dengue virus-like particle vaccine induces high levels of neutralizing antibodies and reduces dengue replication in non-human primates","volume":"98","author":"Thoresen","year":"2024","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.bsheal.2026.06.006_b0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020528","article-title":"DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III","volume":"6","author":"Azevedo","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bsheal.2026.06.006_b0300","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.1900136","article-title":"Combination of modified NS1 and NS3 as a novel vaccine strategy against dengue virus infection","volume":"203","author":"Kao","year":"2019","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bsheal.2026.06.006_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025685","article-title":"Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines","volume":"6","author":"Costa","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0310","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40478-018-0572-7","article-title":"E90 subunit vaccine protects mice from Zika virus infection and microcephaly","volume":"6","author":"Zhu","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"10.1016\/j.bsheal.2026.06.006_b0315","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/cr.2017.53","article-title":"An mRNA-based vaccine strategy against Zika","volume":"27","author":"Wong","year":"2017","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.bsheal.2026.06.006_b0320","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.06.040","article-title":"Vaccine mediated protection against Zika virus-induced congenital disease","volume":"170","author":"Richner","year":"2017","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.bsheal.2026.06.006_b0325","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.vaccine.2023.02.055","article-title":"Generation of a thermostable, oral Zika vaccine that protects against virus challenge in non-human primates","volume":"41","author":"Bacon","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0330","doi-asserted-by":"crossref","first-page":"e01415","DOI":"10.1128\/JVI.01415-20","article-title":"Zika virus-like particles bearing a covalent dimer of envelope protein protect mice from lethal challenge, J.","volume":"95","author":"De Lorenzo","year":"2020","journal-title":"Virol"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0335","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1038\/s41467-024-53242-0","article-title":"A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bsheal.2026.06.006_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109107","article-title":"A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage","volume":"35","author":"Gambino","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0345","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15039-8","article-title":"A Zika vaccine targeting NS1 protein protects immunocompetent adult mice in a lethal challenge model","volume":"7","author":"Brault","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bsheal.2026.06.006_b0350","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/jvi.64.7.3162-3170.1990","article-title":"Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants","volume":"64","author":"Schmaljohn","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.bsheal.2026.06.006_b0355","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2017.12.011","article-title":"Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy","volume":"150","author":"Jiang","year":"2018","journal-title":"Antiviral Res."},{"issue":"10","key":"10.1016\/j.bsheal.2026.06.006_b0360","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1128\/jvi.69.10.6417-6423.1995","article-title":"A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus","volume":"69","author":"Chu","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.bsheal.2026.06.006_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199149","article-title":"Investigation of a subunit protein vaccine for HFRS based on a consensus sequence between envelope glycoproteins of HTNV and SEOV","volume":"334","author":"Liu","year":"2023","journal-title":"Virus Res."},{"key":"10.1016\/j.bsheal.2026.06.006_b0370","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fimmu.2016.00298","article-title":"Structure and function of HLA-A*02-restricted Hantaan virus cytotoxic T-cell epitope that mediates effective protective responses in HLA-A2.1\/Kb transgenic mice","volume":"7","author":"Ma","year":"2016","journal-title":"Front. Immunol."},{"issue":"40","key":"10.1016\/j.bsheal.2026.06.006_b0375","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1016\/j.vaccine.2013.07.025","article-title":"A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS)","volume":"31","author":"Hooper","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.bsheal.2026.06.006_b0380","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fcimb.2020.00333","article-title":"Oral vaccination with recombinant vesicular stomatitis virus expressing Sin Nombre virus glycoprotein prevents Sin Nombre virus transmission in deer mice","volume":"10","author":"Warner","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7","key":"10.1016\/j.bsheal.2026.06.006_b0385","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/v11070645","article-title":"Vesicular stomatitis virus-based vaccines provide cross-protection against Andes and Sin Nombre viruses","volume":"11","author":"Warner","year":"2019","journal-title":"Viruses"},{"issue":"Pt 7","key":"10.1016\/j.bsheal.2026.06.006_b0390","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1099\/0022-1317-83-7-1745","article-title":"Genetic vaccines protect against Sin Nombre hantavirus challenge in the deer mouse (Peromyscus maniculatus)","volume":"83","author":"Bharadwaj","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.bsheal.2026.06.006_b0395","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ymthe.2022.09.016","article-title":"Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model","volume":"31","author":"Hawman","year":"2023","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.bsheal.2026.06.006_b0400","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41564-020-00815-6","article-title":"A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model","volume":"6","author":"Hawman","year":"2021","journal-title":"Nat. Microbiol."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0405","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.1038\/s41598-019-44210-6","article-title":"Vesicular stomatitis virus-based vaccine protects mice against Crimean-Congo hemorrhagic fever","volume":"9","author":"Rodriguez","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bsheal.2026.06.006_b0410","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1121163","article-title":"Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1","volume":"13","author":"Hu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7","key":"10.1016\/j.bsheal.2026.06.006_b0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006628","article-title":"Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge","volume":"12","author":"Zivcec","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0420","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1038\/s41467-024-48555-z","article-title":"Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus","volume":"15","author":"Furey","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bsheal.2026.06.006_b0425","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2231573","article-title":"Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD","volume":"12","author":"Li","year":"2023","journal-title":"Emerg. Microbes Infect."},{"issue":"4","key":"10.1016\/j.bsheal.2026.06.006_b0430","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/vaccines7040195","article-title":"Influenza H1 mosaic hemagglutinin vaccine induces broad immunity and protection in mice","volume":"7","author":"Corder","year":"2019","journal-title":"Vaccines (basel)"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0435","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-024-00891-3","article-title":"Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza a virus challenge","volume":"9","author":"Pascha","year":"2024","journal-title":"npj Vaccines"},{"issue":"24","key":"10.1016\/j.bsheal.2026.06.006_b0440","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1016\/j.vaccine.2006.04.008","article-title":"Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines","volume":"24","author":"Ernst","year":"2006","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.bsheal.2026.06.006_b0445","article-title":"A universal influenza nanovaccine for \u201cmixing vessel\u201d hosts confers potential ability to block cross-species transmission","volume":"8","author":"Ding","year":"2019","journal-title":"Adv. Healthc. Mater."},{"issue":"12","key":"10.1016\/j.bsheal.2026.06.006_b0450","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200065119","article-title":"A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease","volume":"119","author":"Foster","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bsheal.2026.06.006_b0455","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41541-017-0023-7","article-title":"A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model","volume":"2","author":"Walpita","year":"2017","journal-title":"npj Vaccines"},{"key":"10.1016\/j.bsheal.2026.06.006_b0460","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1743-422X-10-353","article-title":"Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease","volume":"10","author":"Mire","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.bsheal.2026.06.006_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104405","article-title":"Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model","volume":"87","author":"de Wit","year":"2023","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.bsheal.2026.06.006_b0470","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1016\/j.ymthe.2025.03.032","article-title":"Single-dose intranasal AdC68-vectored vaccines rapidly protect Syrian hamsters against lethal Nipah virus infection","volume":"33","author":"Lu","year":"2025","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.bsheal.2026.06.006_b0475","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29203","article-title":"SFTSV Gn-Head mRNA vaccine confers efficient protection against lethal viral challenge","volume":"95","author":"Kim","year":"2023","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0480","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1038\/s41467-019-11815-4","article-title":"Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets","volume":"10","author":"Kwak","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0485","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41541-023-00771-2","article-title":"mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice","volume":"8","author":"Kim","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.bsheal.2026.06.006_b0490","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1348276","article-title":"Comparative analysis of the efficacy of vaccines using structural protein subunits of the severe fever with thrombocytopenia syndrome virus","volume":"15","author":"Kim","year":"2024","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.bsheal.2026.06.006_b0495","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/infdis\/175.2.441","article-title":"Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge","volume":"175","author":"Taffs","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0500","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2007.09.029","article-title":"Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens","volume":"371","author":"Sakhatskyy","year":"2008","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0505","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0510","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.bsheal.2026.06.006_b0515","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virol.2011.08.005","article-title":"Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge","volume":"419","author":"Clark","year":"2011","journal-title":"Virology"},{"issue":"25\u201326","key":"10.1016\/j.bsheal.2026.06.006_b0520","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.vaccine.2004.02.034","article-title":"Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB\/c mice from a lethal intranasal poxvirus challenge","volume":"22","author":"Pulford","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.bsheal.2026.06.006_b0525","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.bsheal.2026.06.006_b0530","doi-asserted-by":"crossref","unstructured":"O. Martinez, A. Bravo Cruz, S. Santos, M. Ramirez, E. Miranda, J. Shisler, M. Otero, Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge, Vaccine 35 (44) (2017) 6007\u20136014, https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.091.","DOI":"10.1016\/j.vaccine.2017.05.091"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0535","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12985-024-02534-4","article-title":"Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses","volume":"21","author":"Radaelli","year":"2024","journal-title":"Virol. J."},{"issue":"6","key":"10.1016\/j.bsheal.2026.06.006_b0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003850","article-title":"BoHV-4-based vector single heterologous antigen delivery protects STAT1(-\/-) mice from monkeypoxvirus lethal challenge","volume":"9","author":"Franceschi","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.bsheal.2026.06.006_b0545","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","article-title":"A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease","volume":"187","author":"Zuiani","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0550","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1038\/s41467-025-59826-8","article-title":"Mpox multiprotein virus-like nanoparticle vaccine induces neutralizing and protective antibodies in mice and non-human primates","volume":"16","author":"Belghith","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bsheal.2026.06.006_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105392","article-title":"Single-chain A35R-M1R-B6R trivalent mRNA vaccines protect mice against both mpox virus and vaccinia virus","volume":"109","author":"Kong","year":"2024","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0560","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54909-4","article-title":"A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primates","volume":"15","author":"Ye","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0565","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1038\/s41467-025-58328-x","article-title":"An mRNA vaccine against monkeypox virus inhibits infection by co-activation of humoral and cellular immune responses","volume":"16","author":"Tai","year":"2025","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.bsheal.2026.06.006_b0570","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","article-title":"Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates","volume":"187","author":"Mucker","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bsheal.2026.06.006_b0575","doi-asserted-by":"crossref","first-page":"15711","DOI":"10.1038\/ncomms15711","article-title":"Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge","volume":"8","author":"Bradley","year":"2017","journal-title":"Nat. Commun."},{"issue":"6276","key":"10.1016\/j.bsheal.2026.06.006_b0580","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/345622a0","article-title":"Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160","volume":"345","author":"Berman","year":"1990","journal-title":"Nature"},{"issue":"7383","key":"10.1016\/j.bsheal.2026.06.006_b0585","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature10766","article-title":"Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys","volume":"482","author":"Barouch","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bsheal.2026.06.006_b0590","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1128\/JVI.79.5.2956-2963.2005","article-title":"Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys","volume":"79","author":"Seaman","year":"2005","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.bsheal.2026.06.006_b0595","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3390\/v14081779","article-title":"Construction and evaluation of recombinant adenovirus candidate vaccines for chikungunya virus","volume":"14","author":"Cao","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0600","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-025-02182-2","article-title":"CHIKV mRNA vaccines encoding conserved structural\/envelope proteins confer broad cross-lineage protection against infection","volume":"10","author":"Liang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000928","article-title":"A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates","volume":"5","author":"Mallilankaraman","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bsheal.2026.06.006_b0610","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.598847","article-title":"A monovalent and trivalent MVA-based vaccine completely protects mice against lethal Venezuelan, western, and eastern equine encephalitis virus aerosol challenge","volume":"11","author":"Henning","year":"2021","journal-title":"Front. Immunol."},{"issue":"492","key":"10.1016\/j.bsheal.2026.06.006_b0615","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav3113","article-title":"A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates","volume":"11","author":"Ko","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bsheal.2026.06.006_b0620","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virol.2016.08.023","article-title":"Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses","volume":"499","author":"Rico","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.bsheal.2026.06.006_b0625","doi-asserted-by":"crossref","unstructured":"Z. Jiang, C. Xie, P. Wu, Z. Li, M. Zeng, C. Sun, Discovering broader antiviral strategies: Role of interferon-induced transmembrane proteins in virus infection, hLife 2 (8) (2024) 377\u2013379, https:\/\/doi.org\/10.1016\/j.hlife.2024.07.002.","DOI":"10.1016\/j.hlife.2024.07.002"},{"issue":"5","key":"10.1016\/j.bsheal.2026.06.006_b0630","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bsheal.2023.08.003","article-title":"Advances in treatment strategies for COVID-19: Insights from other coronavirus diseases and prospects","volume":"5","author":"Li","year":"2023","journal-title":"Biosaf. Health"},{"key":"10.1016\/j.bsheal.2026.06.006_b0635","doi-asserted-by":"crossref","unstructured":"S. Chen, Z. Zhang, Q. Wang, P. Li, F. Li, L. Chen, Nasal mucosal secretory immunoglobulin A but not serum antibodies is resistant to Omicron evasion, hLife 2 (9) (2024) 488\u2013491, https:\/\/doi.org\/10.1016\/j.hlife.2024.05.004.","DOI":"10.1016\/j.hlife.2024.05.004"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113609","article-title":"Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in chinese population","volume":"43","author":"Li","year":"2024","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bsheal.2026.06.006_b0645","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41590-023-01715-7","article-title":"Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus","volume":"25","author":"Wang","year":"2024","journal-title":"Nat. Immunol."},{"issue":"15","key":"10.1016\/j.bsheal.2026.06.006_b0650","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.scib.2025.05.013","article-title":"Sterilized protective immunity induced by DAM and DAM+ in mouse models for both VACV and MPXV","volume":"70","author":"Gao","year":"2025","journal-title":"Sci. Bull. (Beijing)"},{"issue":"10","key":"10.1016\/j.bsheal.2026.06.006_b0655","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41591-019-0602-4","article-title":"Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV","volume":"25","author":"Ehrhardt","year":"2019","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.bsheal.2026.06.006_b0660","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.3390\/diagnostics15222845","article-title":"Advances in point-of-care infectious disease diagnostics: Integration of technologies, validation, artificial intelligence, and regulatory oversight","volume":"15","author":"Kardjadj","year":"2025","journal-title":"Diagnostics (basel)"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0665","doi-asserted-by":"crossref","first-page":"e03617","DOI":"10.1128\/mBio.03617-20","article-title":"Mutations in the hemagglutinin stalk domain do not permit escape from a protective, stalk-based vaccine-induced immune response in the mouse model","volume":"12","author":"Roubidoux","year":"2021","journal-title":"mBio"},{"issue":"17","key":"10.1016\/j.bsheal.2026.06.006_b0670","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu9140","article-title":"Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies","volume":"11","author":"Maurer","year":"2025","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.bsheal.2026.06.006_b0675","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/diagnostics11081328","article-title":"Conserved sequence analysis of influenza A virus HA segment and its application in rapid typing","volume":"11","author":"Lin","year":"2021","journal-title":"Diagnostics (basel)"},{"issue":"7417","key":"10.1016\/j.bsheal.2026.06.006_b0680","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza a viruses mediated by a single antibody loop","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bsheal.2026.06.006_b0685","article-title":"Exploring current hypervirulent Klebsiella pneumoniae infections: insights into pathogenesis, drug resistance, and vaccine prospects","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.bsheal.2026.06.006_b0690","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s40121-021-00533-4","article-title":"Current stage in the development of Klebsiella pneumoniae vaccines","volume":"10","author":"Assoni","year":"2021","journal-title":"Infect. Dis. Ther."},{"issue":"12","key":"10.1016\/j.bsheal.2026.06.006_b0695","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1080\/14760584.2021.1984889","article-title":"Recent advances in lipopolysaccharide-based glycoconjugate vaccines","volume":"20","author":"Zhu","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.bsheal.2026.06.006_b0700","doi-asserted-by":"crossref","unstructured":"G. Wong, Progress in elucidating potential markers and mechanisms of rapid protection conferred by the VSV-vectored Ebola virus vaccine, mBio 10 (4) (2019) e01597-19, https:\/\/doi.org\/10.1128\/mBio.01597-19.","DOI":"10.1128\/mBio.01597-19"},{"key":"10.1016\/j.bsheal.2026.06.006_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2023.108283","article-title":"Influence of glycosylation on the immunogenicity and antigenicity of viral immunogens","volume":"70","author":"Newby","year":"2024","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.bsheal.2026.06.006_b0710","unstructured":"World Health Organization, WHO Director-General declares mpox outbreak a public health emergency of international concern. https:\/\/www.who.int\/news\/item\/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern, 2024 (accessed 19 September 2025)."},{"issue":"2","key":"10.1016\/j.bsheal.2026.06.006_b0715","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.chom.2025.01.010","article-title":"A brief history of human infections with H5Ny avian influenza viruses","volume":"33","author":"Wang","year":"2025","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.bsheal.2026.06.006_b0720","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2547736","article-title":"Cattle H5N1 outbreak in US driven by cow's \u201ccross-nursing\u201d behaviour: elucidating a novel transmission mechanism","volume":"14","author":"Hu","year":"2025","journal-title":"Emerg. Microbes Infect."},{"issue":"4","key":"10.1016\/j.bsheal.2026.06.006_b0725","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bsheal.2024.07.002","article-title":"Automated robot and artificial intelligence-powered wastewater surveillance for proactive mpox outbreak prediction","volume":"6","author":"Ou","year":"2024","journal-title":"Biosaf. Health"},{"key":"10.1016\/j.bsheal.2026.06.006_b0730","doi-asserted-by":"crossref","unstructured":"S. Guo, J. Wang, The terra incognita in microbiology for artificial intelligence, and where to go next, hLife 3 (11) (2025) 524\u2013526, https:\/\/doi.org\/10.1016\/j.hlife.2025.06.002.","DOI":"10.1016\/j.hlife.2025.06.002"}],"container-title":["Biosafety and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590053626000959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590053626000959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:18:29Z","timestamp":1787685509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590053626000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":146,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2590053626000959"],"URL":"https:\/\/doi.org\/10.1016\/j.bsheal.2026.06.006","relation":{},"ISSN":["2590-0536"],"issn-type":[{"value":"2590-0536","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The first key for the Priority Pathogens: Protective immunogens in development of vaccines and medications","name":"articletitle","label":"Article Title"},{"value":"Biosafety and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bsheal.2026.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Chinese Medical Association Publishing House Co. Ltd. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}